Acute Leukemias - Republican Scientific Medical Library

a References 201
19. Gill PS, Meyer PR, Pavlova Z, Levine AM (1986) B cell acute lymphocytic
leukemia in adults. Clinical, morphologic, and immunologic
findings. J Clin Oncol 4(5):737
20. Baccarani M, Corbelli G, Amadori S, et al. (1982) Adolescent and
adult acute lymphoblastic leukemia: Prognostic features and outcome
of therapy. A study of 293 patients. Blood 60(3):677
21. Lazzarino M, Morra E, Alessandrino EP, et al. (1982) Adult acute
lymphoblastic leukemia. Response to therapy according to presenting
features in 62 patients. Eur J Cancer Clin Oncol 18(9):813
22. van der Reijden HJ, van Wering ER, van de Rijn JM, et al. (1983)
Immunological typing of acute lymphoblastic leukaemia. Scand
J Haematol 30(4):356
23. Lerede T, Bassan R, Rossi A, et al. (1996) Therapeutic impact of
adult-type acute lymphoblastic leukemia regimens in B-cell/L3
acute leukemia and advanced-stage Burkitt’s lymphoma. Haematologica
81(5):442
24. Clarkson B, Ellis S, Little C, et al. (1985) Acute lymphoblastic leukemia
in adults. Semin Oncol 12(2):160
25. Walters R, Kantarjian H, Keating M, et al. (1986) Effective, low-morbidity,
outpatient induction therapy for adult acute lymphocytic
leukemia (ALL). Proc Am Soc Clin Oncol 4:737
26. Barnett MJ, Greaves MF, Amess JA, et al. (1986) Treatment of acute
lymphoblastic leukaemia in adults. Br J Haematol 64(3): 455
27. Patte C, Philip T, Rodary C, et al. (1986) Improved survival rate in
children with stage III and IV B cell non-Hodgkin’s lymphoma and
leukemia using multi-agent chemotherapy: Results of a study of
114 children from the French Pediatric Oncology Society. J Clin
Oncol 4(8):1219
28. Patte C, Michon J, Frappaz D, et al. (1994) Therapy of Burkitt and
other B-cell acute lymphoblastic leukaemia and lymphoma: Experience
with the LMB protocols of the SFOP (French Paediatric
Oncology Society) in children and adults. Baillieres Clin Haematol
7(2):339
29. Murphy SB, Bowman WP, Abromowitch M, et al. (1986) Results of
treatment of advanced-stage Burkitt’s lymphoma and B cell (SIg+)
acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide
and coordinated high-dose methotrexate and cytarabine.
J Clin Oncol 4(12):1732
30. Rosanda C, Cantu-Rajnoldi A, Invernizzi R, et al. (1992) B-cell acute
lymphoblastic leukemia (B-ALL): A report of 17 pediatric cases.
Haematologica 77(2):151
31. Patte C, Sakiroglu C, Ansoborlo S, Baruchel A, Plouvier E, Pacquement
H, Babin-Boilletot A; Societe Francaise d‘Oncologie Pediatrique
(2002) Urate-oxidase in the prevention and treatment of metabolic
complications inpatients with B-cell lymphoma and leukemia,
treated in the Societe Francaise d‘Oncologie Pediatrique
LMB89 protocol. Ann Oncol 13:789–795
32. Reiter A, Schrappe M, Tiemann M, et al. (1999) Improved treatment
results in childhood B-cell neoplasms with tailored intensification
of therapy: A report of the Berlin-Frankfurt-Munster
Group Trial NHL-BFM 90. Blood 94(10):3294
33. Patte C, Auperin A, Michon J, et al. (2001) The société française
d‘oncologie pédiatrique LMB89 protocol: Highly effective multiagent
chemotherapy tailored to the tumor burden and initial response
in 561 unselected children with B-cell lymphomas and
L3 leukemia. Blood 97:3370–3379
34. Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Pescosta N,
Guarnaccia C, Lewis MS, McKendrick J, Stenning SP, et al.; UKLG
LY06 collaborators (2002) An international evaluation of CO-
DOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma:
Results of United Kingdom Lymphoma Group LY06 study.
Ann Oncol 13:1264–1274
35. Soussain C, Patte C, Ostronoff M, et al. (1995) Small noncleaved
cell lymphoma and leukemia in adults. A retrospective study of
65 adults treated with the LMB pediatric protocols. Blood
85(3):664
36. Troussard X, Leblond V, Kuentz M, et al. (1990) Allogeneic bone
marrow transplantation in adults with Burkitt’s lymphoma or
acute lymphoblastic leukemia in first complete remission. J Clin
Oncol 8(5):809
37. Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman
E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A,et al.;
European Bone Marrow Transplantation (EBMT) Lymphoma Registry
(2003) An EBMT registry matched study of allogeneic stem
cell transplants for lymphoma: Allogeneic transplantation is associated
with a lower relapse rate but a higher procedure-related
mortality rate than autologous transplantation. Bone Marrow
Trans 31:667–678
38. Pees HW, Radtke H, Schwamborn J, Graf N (1992) The BFM-protocol
for HIV-negative Burkitt’s lymphomas and L3 ALL in adult patients:
A high chance for cure. Ann Hematol 65(5):201
39. Todeschini G, Tecchio C, Degani D, et al. (1997) Eighty-one percent
event-free survival in advanced Burkitt’s lymphoma/leukemia: No
differences in outcome between pediatric and adult patients treated
with the same intensive pediatric protocol. Ann Oncol 8(Suppl
1):77
40. Magrath I, Adde M, Shad A, et al. (1996) Adults and children with
small non-cleaved-cell lymphoma have a similar excellent outcome
when treated with the same chemotherapy regimen. J Clin
Oncol 14(3):925
41. Kantarjian HM, O‘Brien S, Smith TL, et al. (2000) Results of treatment
with hyper-CVAD, a dose-intensive regimen, in adult acute
lymphocytic leukemia. J Clin Oncol 18(3):547
42. Hoelzer D, Baur K-H, Giagounidis A, et al. (2003) Short intensive
chemotherapy with Rituximab seems successful in Burkitt NHL,
mature B-ALL and other high-grade B-NHL. Blood 102:70a, (abstr
236)
43. Cabanillas ME, Thomas DA, Cortes J, et al. (2002) Outcome with
hyper-CVAD and Rituximab in Burkitt (BL) and Burkitt-like (BLL)
leukemia/lymphoma. Proc Am Soc Clin Oncol 22:574, (abstr 2309)
44. Preudhomme C, Dervite I, Wattel E, et al. (1995) Clinical significance
of p53 mutations in newly diagnosed Burkitt’s lymphoma
and acute lymphoblastic leukemia: A report of 48 cases. J Clin Oncol
13(4):812
45. Harbott J, Harder S, Haas OA, et al. (2003) Secondary chromosomal
aberrations in childhood Burkitt’s leukemia/lymphoma-analysis
of 182 complete caryotypes of patients treated according to
the German-Austrian-Swiss BFM-NHL trials. Blood 102:11, 887a
46. Poirel HA, Heerema N, Swansbury J, et al. (2003) Prognostic value
of recurrent chromosomal alterations in pediatric B-cell non-
Hodgkin’s lymphoma: Report of 238 cases from the International
FAB/LMB96 study. Blood 102:11, 391a
47. Philip T, Hartmann O, Pinkerton R, et al. (1993) Curability of
relapsed childhood B-cell non-Hodgkin’s lymphoma after intensive
first line therapy: A report from the Societe Francaise d‘Oncologie
Pediatrique. Blood 81(8):2003